Phase II Study of Uracil-Tegafur in Patients with Metastatic Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|62|3|223-227

ISSN： 0030-2414

Source： Oncology, Vol.62, Iss.3, 2002-06, pp. : 223-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic Cancer

By  

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 32-37

Karger

Access to resources Recommend Favorite

Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer

By  

Oncology, Vol. 89, Iss. 3, 2015-05 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

Phase II Trial of Oxaliplatin and Tegafur/Uracil and Oral Folinic Acid for Advanced or Metastatic Colorectal Cancer in Elderly Patients

By  

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

Phase I Study of Paclitaxel and Uracil plus Tegafur Combination in Patients with Pretreated Metastatic Breast Cancer: Drug Sequencing Based on Preclinical Modelling Studies

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 118-124

Karger

Access to resources Recommend Favorite

An Early Phase II Study of S-1 in Patients with Metastatic Pancreatic Cancer

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 171-178

Karger

Access to resources Recommend Favorite